Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 5:11 pm Purchase | 2025-12-31 | 13G | Traws Pharma, Inc. TRAW | Ikarian Capital, LLC | 812,524 9.990% | 223,022 (+37.83%) | Filing History |
| 2026-02-17 12:36 pm Purchase | 2025-12-31 | 13G | Traws Pharma, Inc. TRAW | Squadron Master Fund LP | 713,540 8.900% | 122,540 (+20.73%) | Filing History |
| 2026-02-12 09:11 am Purchase | 2025-12-31 | 13G | Traws Pharma, Inc. TRAW | Adage Capital Management, L.P. | 730,000 9.140% | 400,000 (+121.21%) | Filing History |
| 2026-02-11 09:44 am Sale | 2025-12-31 | 13G | Traws Pharma, Inc. TRAW | Ayrton Capital LLC | 342,935 4.290% | -60,715 (-15.04%) | Filing History |
| 2026-01-16 4:47 pm Purchase | 2026-01-14 | 13G | Traws Pharma, Inc. TRAW | Chernett Jorey | 543,268 6.800% | 543,268 (New Position) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | Traws Pharma, Inc. TRAW | Perceptive Advisors LLC | 886,887 9.990% | 341,690 (+62.67%) | Filing History |
| 2025-11-14 2:29 pm Purchase | 2025-09-30 | 13G | Traws Pharma, Inc. TRAW | Squadron Master Fund LP | 591,000 8.400% | 170,499 (+40.55%) | Filing History |
| 2025-11-13 09:07 am Unchanged | 2025-09-30 | 13G | Traws Pharma, Inc. TRAW | Adage Capital Management, L.P. | 330,000 4.670% | 0 (Unchanged) | Filing History |
| 2025-09-19 3:04 pm Purchase | 2025-09-12 | 13G | Traws Pharma, Inc. TRAW | Squadron Master Fund LP | 420,501 6.000% | 420,501 (New Position) | Filing History |
| 2025-05-15 5:26 pm Purchase | 2025-03-31 | 13G | Traws Pharma, Inc. TRAW | Ikarian Capital, LLC | 589,502 9.990% | 195,247 (+49.52%) | Filing History |
| 2025-05-15 4:30 pm Purchase | 2025-03-31 | 13G | Traws Pharma, Inc. TRAW | Perceptive Advisors LLC | 545,197 9.990% | 158,642 (+41.04%) | Filing History |
| 2025-05-12 09:02 am Purchase | 2025-03-31 | 13G | Traws Pharma, Inc. TRAW | Adage Capital Management, L.P. | 330,000 6.500% | 330,000 (New Position) | Filing History |
| 2025-02-14 4:22 pm Purchase | 2024-12-31 | 13G | Traws Pharma, Inc. TRAW | Alyeska Investment Group, L.P. | 302,252 9.900% | 302,252 (New Position) | Filing History |
| 2025-02-14 1:18 pm Purchase | 2024-12-31 | 13G | Traws Pharma, Inc. TRAW | Ikarian Capital, LLC | 394,255 9.990% | 394,255 (New Position) | Filing History |
| 2025-02-13 1:07 pm Purchase | 2024-12-31 | 13G | Traws Pharma, Inc. TRAW | Ayrton Capital LLC | 403,650 9.900% | 403,650 (New Position) | Filing History |
| 2025-01-29 6:42 pm Purchase | 2024-12-31 | 13D | Traws Pharma, Inc. TRAW | ORBIMED ADVISORS LLC | 760,824 19.900% | 760,824 (New Position) | Filing History |
| 2025-01-08 9:28 pm Purchase | 2024-12-31 | 13G | Traws Pharma, Inc. TRAW | Perceptive Advisors LLC | 386,555 9.900% | 386,555 (New Position) | Filing History |
| 2024-11-06 4:12 pm Unchanged | 2024-11-06 | 13D | Traws Pharma, Inc. TRAW | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-09-23 6:44 pm Unchanged | 2024-09-23 | 13D | Traws Pharma, Inc. TRAW | ORBIMED ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-04-08 9:37 pm Unchanged | 2024-04-08 | 13D | Traws Pharma, Inc. TRAW | Viriom Inc. | 0 0.000% | 0 (Unchanged) | Filing |